NO20064521L - Framgangsmate og blanding for behandling av rhinitt - Google Patents

Framgangsmate og blanding for behandling av rhinitt

Info

Publication number
NO20064521L
NO20064521L NO20064521A NO20064521A NO20064521L NO 20064521 L NO20064521 L NO 20064521L NO 20064521 A NO20064521 A NO 20064521A NO 20064521 A NO20064521 A NO 20064521A NO 20064521 L NO20064521 L NO 20064521L
Authority
NO
Norway
Prior art keywords
rhinitis
treatment
procedure
composition
compositions
Prior art date
Application number
NO20064521A
Other languages
English (en)
Other versions
NO335840B1 (no
Inventor
Lena Pereswetoff-Morath
Anders Carlsson
Original Assignee
Biolipox Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolipox Ab filed Critical Biolipox Ab
Publication of NO20064521L publication Critical patent/NO20064521L/no
Publication of NO335840B1 publication Critical patent/NO335840B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk blanding for behandling av rhinitt f.eks. ved nasal eller okular administrasjon omfattende zwitterionisk cetirizin, et polart lipid liposom og en farmasøytisk-akseptabel vandig bærer. Blandingene er fortrinnsvis naturlig homogene.
NO20064521A 2004-05-11 2006-10-05 Blanding for behandling av rhinitt og anvendelse av og framgangsmåte for framstilling av samme NO335840B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/842,433 US20050255154A1 (en) 2004-05-11 2004-05-11 Method and composition for treating rhinitis
PCT/GB2005/001758 WO2005107711A2 (en) 2004-05-11 2005-05-06 Method and composition for treating rhinitis

Publications (2)

Publication Number Publication Date
NO20064521L true NO20064521L (no) 2007-02-06
NO335840B1 NO335840B1 (no) 2015-03-02

Family

ID=34968224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064521A NO335840B1 (no) 2004-05-11 2006-10-05 Blanding for behandling av rhinitt og anvendelse av og framgangsmåte for framstilling av samme

Country Status (24)

Country Link
US (3) US20050255154A1 (no)
EP (1) EP1771155B1 (no)
JP (1) JP4976283B2 (no)
CN (2) CN1984643A (no)
AT (1) ATE550015T1 (no)
AU (1) AU2005239866B2 (no)
BR (1) BRPI0510778B8 (no)
CA (1) CA2536728C (no)
CY (1) CY1112981T1 (no)
DK (1) DK1771155T3 (no)
EA (1) EA014752B1 (no)
ES (1) ES2395130T3 (no)
HR (1) HRP20120484T1 (no)
IL (1) IL179012A (no)
ME (1) ME01436B (no)
MX (1) MXPA06013121A (no)
NO (1) NO335840B1 (no)
NZ (1) NZ550412A (no)
PL (1) PL1771155T3 (no)
PT (1) PT1771155E (no)
RS (1) RS52311B (no)
SI (1) SI1771155T1 (no)
WO (1) WO2005107711A2 (no)
ZA (1) ZA200608407B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
EP1888033B1 (en) 2005-06-09 2014-02-19 Meda AB Method and composition for treating inflammatory disorders
FR2900576B1 (fr) * 2006-05-03 2008-09-19 Centre Nat Rech Scient Procede de concentration extemporanee et reversible de liposomes.
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
US8410085B2 (en) 2007-11-16 2013-04-02 Baylor College Of Medicine Phospholipid compositions and uses thereof
EP2296711A2 (en) * 2008-05-29 2011-03-23 MDRNA, Inc. Multi-arm amines and uses thereof
PT3943069T (pt) 2009-03-17 2025-02-21 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8524692B2 (en) * 2010-04-29 2013-09-03 Georgia Health Sciences University Research Institute, Inc. Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
JP2013535456A (ja) * 2010-07-28 2013-09-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び炎症性疾患の治療用医薬組成物
CN102525921B (zh) 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
KR101475776B1 (ko) * 2012-08-24 2014-12-24 영진약품공업 주식회사 이중 포화 인지질을 포함하는 안정한 피부 외용 조성물
CN104887635B (zh) * 2015-05-20 2019-06-11 苏州东瑞制药有限公司 一种盐酸西替利嗪片及其制备工艺
CN109639410B (zh) * 2018-10-31 2021-04-06 创新先进技术有限公司 基于区块链的数据存证方法及装置、电子设备
US20220395438A1 (en) * 2019-11-04 2022-12-15 Universitat Autonoma De Barcelona Tooth whitening composition
CN114392235B (zh) * 2022-01-28 2023-06-27 成都大学 盐酸西替利嗪眼用脂质体、原位凝胶及其制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
GB8522964D0 (en) 1985-09-17 1985-10-23 Biocompatibles Ltd Aerosol
AU7543887A (en) 1986-06-12 1988-01-11 Liposome Company, Inc., The Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
ES2036593T3 (es) 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
WO1990014105A1 (en) 1989-05-15 1990-11-29 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
HUT75162A (en) * 1993-11-16 1997-04-28 Depotech Corp Vesicles with controlled release of actives
DE4341472A1 (de) 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
AU691249B2 (en) * 1994-02-04 1998-05-14 Lipocore Holding Ab Bilayer preparations
US6773719B2 (en) * 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
KR970706267A (ko) * 1994-09-23 1997-11-03 다니엘 에이치. 페트리 비만 세포 염증성 질환 치료용 조성물 및 방법(compositions and methods for treating mast-cell inflammatory condition)
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US5783566A (en) * 1996-05-10 1998-07-21 California Institute Of Technology Method for increasing or decreasing transfection efficiency
CA2256721A1 (en) 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
IL131492A0 (en) 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
EP0993643A1 (en) * 1997-07-04 2000-04-19 Torsana Osteoporosis Diagnostics A/S A method for estimating the bone quality or skeletal status of a vertebrate
CZ20012038A3 (cs) * 1998-12-23 2001-09-12 Idea Ag Zdokonalený přípravek pro topické, neinvazivní použití in vivo
GR1003359B (el) 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
US6613352B2 (en) * 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
AU2001260270A1 (en) * 2000-05-02 2001-11-12 Pharmacept Gmbh Liposomes containing active substances
JP4623931B2 (ja) 2000-12-07 2011-02-02 エンセラデュス、ファーマシューティカルズ、ベスローテン、フェンノートシャップ 炎症性疾患の治療用組成物
US20030144336A1 (en) * 2001-08-27 2003-07-31 Pfizer Inc. Method of selecting nonsedating H1-antagonists
US20030054030A1 (en) * 2001-09-13 2003-03-20 Gary Gordon Method and compositions for the treatment of pruritus
ATE317268T1 (de) 2001-12-05 2006-02-15 Alcon Inc Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis
AU2003252187A1 (en) 2002-05-15 2003-12-02 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
EP1371362A1 (en) 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
US20040192601A1 (en) * 2002-08-02 2004-09-30 Silvia Corvera Lipid binding molecules and methods of use
JP2004168709A (ja) * 2002-11-20 2004-06-17 Nidek Co Ltd 抗アレルギー点眼点鼻用組成物
US20040198743A1 (en) * 2003-01-31 2004-10-07 Schering Corporation Methods for treating allergic skin and allergic ocular conditions using combinations of histamine receptor antagonists
US20050112199A1 (en) * 2003-09-24 2005-05-26 Mahesh Padval Therapeutic regimens for administering drug combinations
WO2005039533A1 (en) 2003-10-15 2005-05-06 Medigene Ag Method of administering cationic liposomes comprising an active drug
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法

Also Published As

Publication number Publication date
SI1771155T1 (sl) 2012-09-28
CY1112981T1 (el) 2016-04-13
CA2536728C (en) 2011-02-01
EP1771155B1 (en) 2012-03-21
JP2007537220A (ja) 2007-12-20
DK1771155T3 (da) 2012-07-09
JP4976283B2 (ja) 2012-07-18
BRPI0510778A (pt) 2007-11-20
AU2005239866B2 (en) 2010-03-04
NZ550412A (en) 2010-08-27
HK1098960A1 (en) 2007-08-03
CN1984643A (zh) 2007-06-20
MXPA06013121A (es) 2007-05-16
BRPI0510778B1 (pt) 2020-03-10
US9980959B2 (en) 2018-05-29
CN103271910A (zh) 2013-09-04
WO2005107711A3 (en) 2006-03-16
US20070026058A1 (en) 2007-02-01
CA2536728A1 (en) 2005-11-17
US20050255154A1 (en) 2005-11-17
EA014752B1 (ru) 2011-02-28
NO335840B1 (no) 2015-03-02
CN103271910B (zh) 2018-11-06
AU2005239866A1 (en) 2005-11-17
RS52311B (sr) 2012-12-31
ME01436B (me) 2012-12-31
US20130039969A1 (en) 2013-02-14
EP1771155A2 (en) 2007-04-11
EA200602092A1 (ru) 2007-06-29
PT1771155E (pt) 2012-05-15
ATE550015T1 (de) 2012-04-15
BRPI0510778B8 (pt) 2021-05-25
WO2005107711A2 (en) 2005-11-17
ES2395130T3 (es) 2013-02-08
IL179012A0 (en) 2007-03-08
PL1771155T3 (pl) 2012-08-31
ZA200608407B (en) 2007-12-27
US20180104238A9 (en) 2018-04-19
IL179012A (en) 2014-11-30
HRP20120484T1 (hr) 2012-07-31

Similar Documents

Publication Publication Date Title
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
DE602006006308D1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
NO20075136L (no) Nye liposompreparater
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
NO20065904L (no) Terapeutiske forbindelser
CR7362A (es) Formulaciones farmaceuticas de derivado de platino
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
NO20065878L (no) Terapeutiske forbindelser
CY1108676T1 (el) Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
TW200626132A (en) Topical nepafenac formulations
CY1106409T1 (el) Παραγωγα κινολινης
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
NO20080035L (no) Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
SE0303135D0 (sv) Controlled food effect composition
SE0103210D0 (sv) New formulations and use thereof
NO20075508L (no) Stannsoporfinpreparater og administrering

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees